Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain

International Immunology

Volumn 19, Issue 12, 2007, Pages 1395-1402

  Pellegrini, Andrea ^a   Guiñazú, Natalia ^a   Aoki, Maria Pilar ^a   Calero, Isabel Chico ^b   Carrera Silva, Eugenio Antonio ^a   Girones, Nuria ^b   Fresno, Manuel ^b   Gea, Susana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Animal models; B cells; Cytokines

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; CRUZIPAIN; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; BAGG ALBINO MOUSE; C57BL 6 MOUSE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GERMINAL CENTER; HOST SUSCEPTIBILITY; IMMUNOPATHOGENESIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECONDARY IMMUNE RESPONSE; SPLEEN CELL; STRAIN DIFFERENCE; TRYPANOSOMA CRUZI;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD86; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; CYSTEINE ENDOPEPTIDASES; CYTOKINES; FEMALE; GERMINAL CENTER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPECIES SPECIFICITY; SPLEEN;

EID: 36249011970     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm107     Document Type: Article

References (47)

1. Mizoguchi, A. and Bhan, A. K. 2006. A case for regulatory B cells. J. Immunol. 176:705.
2. Shinall, S. M., Gonzalez-Fernandez, M., Noelle, R. J. and Waldschmidt, T. J. 2000. Identification of murine-germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens. J. Immunol. 164:5729.
3. Grammer, A. C., Slota, R., Fischer, R. et al. 2003. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Invest. 112:1506.
4. Marshall-Clarke, S., Tasker, L., Heaton, M. and Parkhouse, R. 2003. A differential requirement for phosphoinositide 3-kinase reveals two pathways for inducible upregulation of major histocompatibility complex class II molecules and CD86 expression by murine B lymphocytes. Immunology 109:102.
5. Hussain, S. and Delovitch, T. L. 2005. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J. Immunol. 174:680.
6. Fecteau, J. F. and Neron, S. 2003. CD40 stimulation of human peripheral B lymphocytes: Distinct response from naive and memory cells. J. Immunol. 171:4621.
7. Zhang, P., Martin, M., Yang, Q.-B., Michalek, S. M. and Katz, J. 2004. Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis. Infect. Immun. 72:637.
8. Nakajima, A., Watanabe, N., Yoshino, S., Yagita, H., Okumura, K. and Azuma, M. 1997. Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int. Immunol. 9:637.
9. Freeman, G., Boussiotis, V., Anumanthan, A. et al. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
10. WHO 2002. Control of Chagas Disease. Report of a WHO Expert Committee. WHO Tech. Rep. Ser. 905:1.
11. Girones, N. and Fresno, M. 2003. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol. 19:19.
12. Leon, J. and Engman, D. 2003. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front. Biosci. 8:e315.
13. Kierszenbaum, F. 2003. Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol. Med. Microbiol. 37:1.
14. Cazzulo, J., Cazzulo Franke, M., Martinez, J. and Franke de Cazzulo, B. 1990. Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi. Biochim. Biophys. Acta. 1037:186.
15. Souto-Padron, T., Campetella, O., Cazzulo, J. and de Souza, W. 1990. Cysteine proteinase in Trypanosoma cruzi immunocyto-chemical localization and involvement in parasite-host cell interaction. J. Cell Sci. 96:485.
16. Arnholdt, A., Piuvezam, M., Russo, D. et al. 1993. Analysis and partial epitope mapping of human T cell-responses to Trypanosoma cruzi cysteinyl proteinase. J. Immunol. 151:3171.
17. Laderach, D., Cerban, F., Motran, C., Vottero de Cima, E. and Gea, S. 1996. Trypanosoma cruzi the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII). Int. J. Parasitol. 26:1249.
18. Giordanengo, L., Guinazu, N., Stempin, C., Fretes, R., Cerban, F. and Gea, S. 2002. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 32:1003.
19. Guinazu, N., Pellegrini, A., Giordanengo, L. et al. 2004. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice. Microbes Infect. 6:1250.
20. Giordanengo, L., Maldonado, C., Rivarola, H. et al. 2000. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur. J. Immunol. 30:3181.
21. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M., Bluethmann, H. and Kohler, G. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
22. Huang, S., Hendriks, W., Althage, A. et al. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742.
23. Carsetti, R., Rosado, M. and Wardmann, H. 2004. Peripheral development of B cells in mouse and man. Immunol. Rev. 197:179.
24. Ridderstad, A. and Tarlinton, D. M. 1998. Kinetics of establishing the memory B cell population as revealed by CD38 expression. J. Immunol. 160:4688.
25. Calame, K. 2001. Plasma cells: Finding new light at the end of B cell development. Nat. Immunol. 2:1103.
26. Lund, F., Garvy, B., Randall, T. and Harris, D. 2005. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8:25.
27. Duddy, M. E., Alter, A. and Bar-Or, A. 2004. Distinct profiles of human B cell effector cytokines: A role in immune regulation? J. Immunol. 172:3422.
28. Harris, D., Haynes, L., Sayles, P. et al. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1:475.
29. Harris, D. P., Goodrich, S., Mohrs, K., Mohrs, M. and Lund, F. E. 2005. Cutting edge: The development of IL-4-producing B cells (B effector 2 cells) is controlled by IL-4, IL-4 receptor {alpha}, and Th2 cells. J. Immunol. 175:7103.
30. Won, W.-J. and Kearney, J. F. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168:5605.
31. Wolniak, K., Shinall, S. and Waldschmidt, T. 2004. The germinal center response. Crit. Rev. Immunol. 24:39.
32. Johansson-Lindbom, B. and Borrebaeck, C. A.K. 2002. Germinal center B cells constitute a predominant physiological source of IL-4: Implication for Th2 development in vivo. J. Immunol. 168:3165.
33. Noelle, R. and Erickson, L. 2005. Determinations of B cell fate in immunity and autoimmunity. Curr. Dir. Autoimmun. 8:1.
34. William, J., Euler, C., Primarolo, N. and Shlomchik, M. J. 2006. B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J. Immunol. 176:2142.
35. Viale, A., Coutinho, A. and Freitas, A. 1992. Differential expression of VH gene families in peripheral B cell repertoires of newborn or adult immunoglobulin H chain congenic mice. J. Exp. Med. 175:1449.
36. Clark, M., Massenburg, D., Siemasko, K., Hou, P. and Zhang, M. 2004. B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway. Curr Opin. Immunol. 16:382.
37. Hussain, S., Salojin, K. V. and Delovitch, T. L. 2004. Hyper-responsiveness, resistance to B-cell receptor-dependent activation-induced cell death, and accumulation of hyperactivated B-cells in islets is associated with the onset of insulitis but not type 1 diabetes. Diabetes 53:2003.
38. Baumgarth, N. 2000. Two-phase model of B-cell activation. Immunol. Rev. 176:171.
39. Valle, A., Zuber, C., Defrance, T., Djossou, O., De Rie, M. and Banchereau, J. 1989. Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol. 19:1463.
40. Sasaki, T., Hoshida, Y., Xu, J. et al. 2005. Prognostic significance of CD40 expression in malignant lymphoma developing in rheumatoid arthritis. J. Cancer Res. Clin. Oncol. 131:797.
41. Bartlett, W. and Noelle, R. 1987. A cell surface ELISA to detect interleukin-4-induced class II MHC expression on murine B cells. J. Immunol. Methods. 105:79.
42. Crow, M. 2006. Modification of accessory molecule signaling, Springer Semin. Immunopathol. 27:409.
43. Yip, H. C., Karulin, A. Y., Tary-Lehmann, M. et al. 1999. Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response. J. Immunol. 162:3942.
44. Maletto, B., Ropolo, A., Moron, V. and Pistoresi-Palencia, M. C. 2002. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice. J. Leukoc. Biol. 72:447.
45. Lombard-Platet, S., Meyer, V. and Ceredig, R. 1997. Both IFN-gamma and IL-4 induce MHC class II expression at the surface of mouse pro-B cells. Dev. Immunol. 5:115.
46. Whitley, M., Cheng, H., Tomasi, T. and Boothby, M. 1993. Distinct IL-4 response mechanisms of the MHC gene A alpha in different mouse B cell lines. Mol. Immunol. 30:821.
47. Roos, A., Schilder-Tol, E., Chand, M. et al. 1998. Differential regulation of expression of the MHC class II molecules RT1.B and RT1.D on rat B lymphocytes: Effects of interleukin-4, interleukin-13 and interferon-gamma. Immunology 93:33.